Senestech (SNES) Lytham Partners 2025 Industrials & Basic Materials Investor Summit summary
Event summary combining transcript, slides, and related documents.
Lytham Partners 2025 Industrials & Basic Materials Investor Summit summary
26 Dec, 2025Company overview and product evolution
Focuses on humane rodent control through fertility management, targeting rats and mice with non-lethal solutions.
Shifted from liquid ContraPest to solid Evolve products, improving usability, shelf life, and market reach.
Evolve products use natural, food-grade ingredients and are exempt from EPA registration under 25(b).
Evolve Rat launched in January 2024; Evolve Mouse followed in May 2024.
Evolve products now account for about 70% of total sales within their first year.
Market growth and distribution strategy
Achieved 70% revenue growth in Q4, driven by Evolve product lines.
Adopted a six-channel distribution strategy: pest control, agribusiness, international, e-commerce, retail, and direct sales.
Established 11 exclusive international distributors in regions including Australia, New Zealand, Hong Kong, Singapore, and the Netherlands.
E-commerce sales surged 206% quarter over quarter, with strong growth on Amazon, Walmart.com, and TractorSupply.com.
Retail expansion includes Ace Hardware and ongoing discussions with Tractor Supply and other brick-and-mortar stores.
Municipal and international deployments
Municipal pilot programs underway in New York City, Chicago, Los Angeles, Boston, and Baltimore.
New York City to begin a pilot in April, deploying bait stations in two 10-block areas, with potential for significant expansion.
Chicago neighborhoods have started initial deployments in April.
Product approved in 45 U.S. states; international approvals and shipments to Hong Kong, UAE, Netherlands, and Maldives.
New Zealand approval expected by October, with product shipments planned.
Latest events from Senestech
- E-commerce drove 20% revenue growth, margin gains, and cash runway extends to Q2 2027.SNES
Q4 202512 Mar 2026 - Record revenue and margin gains, but cash constraints require new financing for profitability.SNES
Q2 20241 Feb 2026 - Record growth fueled by innovative fertility control products and expanding global distribution.SNES
Lytham Partners Fall 2024 Investor Conference20 Jan 2026 - Record Q3 revenue and margin gains fueled by Evolve products and e-commerce growth.SNES
Q3 202414 Jan 2026 - Record 70% revenue growth and 61% margin drive progress toward profitability.SNES
Q4 202424 Dec 2025 - Resale of 1.5M+ shares from warrant exercises funds humane rodent control, but financial risk remains.SNES
Registration Filing16 Dec 2025 - Resale of 1,036,279 shares tied to warrant exercises supports operations amid ongoing losses.SNES
Registration Filing16 Dec 2025 - Innovative pest control firm seeks up to $15M via flexible at-the-market equity offering.SNES
Registration Filing16 Dec 2025 - Offering up to $15M in securities amid ongoing losses and regulatory-driven growth plans.SNES
Registration Filing16 Dec 2025